Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Homepage
Tags search
Amgen

CTech 24/7

09:00 Vast Data eyes $25 billion valuation amid AI boom
21:50 eToro’s Wall Street honeymoon ends abruptly after first earnings call
21:27 Hypernative raises $40M Series B to build the security infrastructure Web3 lacks
20:42 Andreessen Horowitz targets elite IDF alumni for startup accelerator

Amgen

2 stories about Amgen

Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement
03.01.19|Lilach BaumerIn December, Teva reached a confidential settlement and licensing agreement with drug manufacturer Neos Therapeutics, regarding its generic version for Neos' ADHD drug
Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal
12.12.18|Lilach BaumerThe deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments

Twitter

Facebook

Rss

About CTech Terms of Use Privacy Policy

CTech 24/7

Amgen

Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement

Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal